Antigen-specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy.

Saved in:
Bibliographic Details
Title: Antigen-specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy.
Authors: Kelderman S; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Heemskerk B; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Fanchi L; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Philips D; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Toebes M; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kvistborg P; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Buuren MM; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Rooij N; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Michels S; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Germeroth L; Stage Cell Therapeutics GmbH, Göttingen, Germany., Haanen JB; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schumacher NM; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Source: European journal of immunology [Eur J Immunol] 2016 Jun; Vol. 46 (6), pp. 1351-60. Date of Electronic Publication: 2016 May 03.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1521-4141
DOI:10.1002/eji.201545849